Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $2.71 million. The enterprise value is -$3.39 million.
| Market Cap | 2.71M |
| Enterprise Value | -3.39M |
Important Dates
The last earnings date was Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 4.51 million shares outstanding. The number of shares has increased by 797.06% in one year.
| Current Share Class | 4.51M |
| Shares Outstanding | 4.51M |
| Shares Change (YoY) | +797.06% |
| Shares Change (QoQ) | +1.58% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 4.22% |
| Float | 4.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.73 |
| Quick Ratio | 4.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.24 |
Financial Efficiency
Return on equity (ROE) is -311.00% and return on invested capital (ROIC) is -134.27%.
| Return on Equity (ROE) | -311.00% |
| Return on Assets (ROA) | -105.56% |
| Return on Invested Capital (ROIC) | -134.27% |
| Return on Capital Employed (ROCE) | -155.17% |
| Weighted Average Cost of Capital (WACC) | 28.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.28M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -159,535 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.98% in the last 52 weeks. The beta is 1.26, so Oragenics's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -85.98% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.90 |
| Relative Strength Index (RSI) | 48.28 |
| Average Volume (20 Days) | 54,846 |
Short Selling Information
The latest short interest is 656,580, so 14.55% of the outstanding shares have been sold short.
| Short Interest | 656,580 |
| Short Previous Month | 703,470 |
| Short % of Shares Out | 14.55% |
| Short % of Float | 14.84% |
| Short Ratio (days to cover) | 11.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.39M |
| Operating Income | -9.59M |
| Pretax Income | -9.99M |
| Net Income | -9.83M |
| EBITDA | n/a |
| EBIT | -9.59M |
| Earnings Per Share (EPS) | -$3.19 |
Balance Sheet
The company has $6.11 million in cash and $56,134 in debt, with a net cash position of $6.05 million or $1.34 per share.
| Cash & Cash Equivalents | 6.11M |
| Total Debt | 56,134 |
| Net Cash | 6.05M |
| Net Cash Per Share | $1.34 |
| Equity (Book Value) | 6.18M |
| Book Value Per Share | 1.41 |
| Working Capital | 6.18M |
Cash Flow
| Operating Cash Flow | -9.33M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -3.08M |
| Free Cash Flow | -9.33M |
| FCF Per Share | -$2.07 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Oragenics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -797.06% |
| Shareholder Yield | -797.06% |
| Earnings Yield | -369.08% |
| FCF Yield | -350.61% |
Analyst Forecast
The average price target for Oragenics is $2.00, which is 233.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 233.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 3, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |